Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Prostate-Specific Antigen Glycomics Assay for the Early Detection of Prostate Cancer

NCT04393376 is registered in ClinicalTrials.gov with Prof.dr. H.P. Beerlage as lead sponsor.

NCT NCT04393376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04393376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Prostate-Specific Antigen Glycomics Assay for the Early Detection of Prostate Cancer
Lead sponsor
Prof.dr. H.P. Beerlage
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2020
Completion date
August 1, 2025
Enrollment
150 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, psa